On June 2, a group of leading scientists announced their intention to build an entire human genome from scratch. While the fabricated genome would be inserted into cells in a...

The first uterus transplant in the United States was performed on February 24, raising hope that more women will be able to become pregnant and give birth but also raising...

Gene editing, end-of-life care, ethical oversight of research – these are just some of the many bioethics-related topics that Hastings Center scholars study, write about, and discuss with the press....

A landmark international meeting took place in Washington on December 1 – 3 in which scientists, ethicists, policymakers, and others discussed the promises and risks of using powerful new tools...

In two major decisions, the Supreme Court advanced access to health care and human rights. King v Burwell upheld the use of federal tax credits to help people in need...

Leading biologists made front-page news last month by calling for a moratorium on the use of powerful new tools for editing the human genome. While these tools raise hopes of...

A controversial assisted reproduction technique became legal in the first country in the world on February 24 following a vote by both houses of the U.K.’s parliament. While the decision affects...

Bioethics is frequently in the news. Even if the word itself doesn’t appear—and it usually doesn’t—bioethics questions and ideas are there, in stories about care near the end of life,...

Several recent news reports have drawn comparisons between the response to Ebola and the response to AIDS in the early days of that epidemic. In both cases there were questions...

“The Supreme Court’s ruling in Burwell, Secretary of Health and Human Services, et al. v. Hobby Lobby Stores, Inc., et al., could undermine a central goal of the Patient Protection...

Health care providers have a moral obligation to disclose out-of-pocket costs before patients receive care, concludes an article by Alicia Hall in the May-June Hastings Center Report. While information about...

A blood test given to healthy people ages 70 and older predicted with more than 90 percent accuracy who would develop Alzheimer’s disease or mild cognitive impairment (often a precursor...

The U.S. Food and Drug Administration held public hearings on February 25 and 26 to consider whether to permit scientists to begin human testing of a new method of assisted...